Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from Bosentan to Ambrisentan in PAH
NCT01330108Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- May 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ambrisentan in pulmonary arterial hypertension (PAH), sponsored by University of Alabama at Birmingham. Started May 2011; status: completed.
02
Drugs
ambrisentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01330108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01330108.